Alpha-1-antitrypsin inhalation (Grifols)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAlpha-1-antitrypsin inhalation (Grifols)
Drug Alias NameAlpha-1 HCAlpha-1 HC aerosolVR-179
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrifols Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksWikipedia